Detalhe da pesquisa
1.
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Clin Cancer Res
; 29(11): 2052-2065, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928921
2.
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.
Clin Cancer Res
; 28(24): 5306-5316, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222848